News & Events

≪ Back to All News & Events

August 15, 2013

Noxilizer Announces Mike Valentine, Vice President of North American Sales

Noxilizer Announces Mike Valentine, Vice President of North American Sales

Experienced sterilization sales executive, Mike Valentine to build and lead Noxilizer’s sales organization

(Baltimore, MD–August 15, 2013) Noxilizer, Inc., the company advancing a unique and superior, room temperature NO2-based sterilization technology for life science manufacturers, is pleased to announce the appointment of Mr. Michael Valentine as Vice President of North American Sales.

“Mike brings over 20 years of distinguished experience in sales and customer relationship management to the Noxilizer team,” notes President and CEO, Lawrence Bruder. “He has a well-established reputation in the medical device sterilization market. Combined with extensive experience initiating start-up activities for business units and building technical sales teams, Mike will catapult our sales effort and rapidly advance the adoption of NO2 instrument, consumable, and contract sterilization services in the US market.”

Mike has a history of building strong working relationships with customers throughout an impressive professional career with leading medical device manufacturers of sterilization equipment and services including: Getinge USA, Advanced Sterilization Products (ASP), a Johnson & Johnson Company, and Medivators Corporation. Most recently, Mike served as Director of Infection Prevention and Control Chemistries for Medivators Corporation, building the contract sterilization business for single use products. Prior to Medivators, he was instrumental in developing the Life Science business unit for ASP. Mike earned a Bachelor of Science in Electrical Engineering (BSEE) from the University of Massachusetts at Amherst.

“I am fortunate to join a dedicated and talented team at Noxilizer. I look forward to advancing the most innovative sterilization solution in years, to the market I have spent most of my life serving,” says Valentine. “Alternative sterilization technologies are providing new possibilities. Customers are already recognizing the value of NO2 technology and benefitting from the contract sterilization services and in-house use of the RTS 360 Industrial NO2 Sterilizer.” NO2 is highly-compatible with a wide range of temperature-sensitive products like bioresorbable implants, prefilled syringes and other drug-device combination products. It provides a safer, simpler, more economical alternative for manufacturers.

Mike will be building out the Noxilizer sales team this fall. And as Noxilizer completes the installation of multiple sterilization units to customers, additional hiring to support the growing commercial organization will take place.

About Noxilizer, Inc.:

Noxilizer’s unique and superior room temperature NO2-based sterilization technology is revolutionizing two major sterilization markets — medical device/pharmaceutical/biotechnology manufacturing and hospitals. In the manufacturing market, Noxilizer provides sterilization services for medical devices and drug-device combination products. Noxilizer sells the RTS 360 Industrial NO2 Sterilizer to companies who sterilize products in-house and also offers contract sterilization services. In hospitals, Noxilizer is developing a system especially for sensitive, high-tech equipment used in minimally-invasive surgical procedures. Noxilizer is headquartered in Baltimore, MD with offices in the US and Japan. Noxilizer, Inc. is privately held and was founded in 2004. For more information about Noxilizer, please visit:

Media Contact:

Angie Kearns
Brand Manager
Noxilizer, Inc.
” C (574) 304-1502

> Click here to Download PDF